People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DermOQ, Inc. | — | Biotechnology | Series A | $8.4M | $55.1M | 2024 |
| Tetrous, Inc. | — | Biotechnology | Pre-Seed | $445K | $2.9M | 2023 |
Frank E. Phillips at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Frank E. Phillips on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bradley E. Patt | 1 | 3 |
| Melissa E. Jochim | 1 | 1 |
| Gerard Camme | 1 | 1 |
| Nima E. Gharavi | 1 | 1 |
| Patt E. Bradley | 1 | 1 |
| Nikhil E. Verma | 1 | 1 |
| Jan E. Iwanczyk | 1 | 1 |
| John E. Bojanowski | 1 | 1 |
| Gunnar E. Andersson | 1 | 1 |
| Andy E. Carter | 1 | 1 |
| Neel E. Anand | 1 | 1 |
| Simon E. Berry | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.